Association of Laboratory Parameters with Acute Kidney Injury in Pediatric Patients Undergoing Surgery for Transposition of the Great Arteries.

Ainamkoz Amanzholova, Ainamkoz Amazholova, Marina Morenko, Bolat Bekishev, Tatyana Ivanova-Razumova, Sergey Baiko, Nazym Nigmatullina, Dariga Koichubayeva, Azhar Zhailauova

Journal: La Clinica terapeutica 2026;177(1):83-92

PMID: 41525117

Abstract

BACKGROUND

Acute kidney injury (AKI) is a serious complication in children undergoing surgery for transposition of the great arteries (TGA) and can adversely affect postoperative outcomes. Early identification of prognostic laboratory indicators may improve detection and prevention.

METHODS

This prospective study included 150 children (mean age 6 months) undergoing TGA correction at the National Research Cardiac Surgery Center in Astana, Kazakhstan, from January 2021 to December 2023. Participants were divided into experimental and control groups (n = 75 each). Laboratory parameters, including creatinine, urea, electrolytes, C-reactive protein (CRP), and oxidative stress markers, were assessed pre- and postoperatively. Hemodynamic parameters and hourly diuresis were monitored during and after surgery. Logistic regression, correlation analysis, and Kaplan-Meier analysis were used to identify predictors of AKI.

RESULTS

Preoperative creatinine (OR = 1.05, 95% CI: 1.02-1.08, p < 0.01) and CRP (OR = 1.08, 95% CI: 1.03-1.13, p < 0.01) were indepen-dently associated with AKI development. Median time to AKI onset was shorter in the experimental group (1.5 vs. 2 days, p = 0.03), reflecting earlier detection likely due to more intensive monitoring. Children who developed AKI had longer ICU stays (median 7 vs. 5 days, p < 0.01).

CONCLUSIONS

Preoperative creatinine and CRP are reliable early indicators of AKI risk in pediatric TGA surgery. Systematic postoperative monitoring of laboratory parameters and diuresis allows timely detection and intervention, potentially improving outcomes. Future multicen-ter studies are warranted to validate these predictors and optimize risk stratification protocols.

Address: Department of Childhood Diseases with Courses in Allergology, Immunology, Hematology and Endocrinology, NJSC "Astana Medical University", Beibitshilik str., 49a, Astana, 010000, Kazakhstan.; Laboratory of Extracorporeal Hemocorrection, Corporate Fund University Medical Center "Heart Center", Turan str., 38, Astana, 010000, Kazakhstan.; Department of Pediatrics, Corporate Fund University Medical Center "Heart Center", Turan str., 38, Astana, 010000, Kazakhstan.; National Center for Pediatric Nephrology and Renal Replacement Therapy, Belarusian State Medical University, Dzerzhinski Ave., 83, Minsk, 220083, Belarus.; Department of Nephrology, Asfendiyarov Kazakh National Medical University, Tole be str., 94, Almaty, 050002, Kazakhstan.; Department of Surgery, Nazarbayev University School of Medicine, Kerey and Zhanibek Khandar Str., 5/1, Astana, 010000, Kazakhstan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.